XML 79 R7.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities      
Net income $ 17,034 $ 45,885 $ 126,959
Adjustments to reconcile net income to net cash (used in) provided by operating activities:      
Depreciation and amortization 7,880 5,772 5,002
Deferred income taxes 3,304 11,209 (82,085)
Stock-based compensation expense 8,173 7,784 5,672
Provision for doubtful accounts 818    
Provision for excess and obsolete inventory 2,794 2,205 8,135
Changes in operating assets & liabilities:      
Accounts receivable (6,002) (3,877) (23,573)
Inventories (17,953) (10,512) (10,567)
Prepaid expenses and other current assets (104) (1,436) (3,866)
Accounts payable and other current liabilities (19,150) (703) 25,000
Deferred revenue 6,672 6,055 7,079
Income taxes (162) 196 14
Other assets and liabilities (16,898) (15,613) (1,486)
Net cash (used in) provided by operating activities (13,594) 46,965 56,284
Cash flows from investing activities      
Expenditures for property, plant and equipment and capitalized software (11,969) (4,715) (7,285)
Net cash used in investing activities (11,969) (4,715) (7,285)
Cash flows from financing activities      
Net settlement on restricted stock grants (1,632) (1,419) (1,184)
Repurchase of common stock (17,744)    
Proceeds from Employee Stock Purchase Plan 863 871 739
Proceeds from exercise of stock options 5,105 1,734 15,515
Net cash (used in) provided by financing activities (13,408) 1,186 15,070
Effect of exchange rate changes on cash and cash equivalents 603 586 (844)
Net (decrease) increase in cash, cash equivalents and restricted cash (38,368) 44,022 63,225
Cash, cash equivalents and restricted cash at beginning of period 184,902 140,880 77,655
Cash, cash equivalents and restricted cash at end of period 146,534 184,902 140,880
Supplemental disclosure of cash flow information      
Income taxes 1,028 858 583
Interest $ 5,207 $ 5,470 $ 5,315